PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ProMIS Neurosciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23+0.08 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $75.24M
- P/E (TTM)
- –
- Dividend yield
- –
ProMIS Neurosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Market Cap | $73.80M | $166.30M |
| Enterprise Value | $20.34M | $88.19M |
| PB Ratio | 1.49 | 2.03 |
| P/TBV Ratio | 1.49 | 2.29 |
Income (trailing twelve months)
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Operating Income | -$43.43M | -$21.40M |
| Net Income | -$42.23M | -$22.46M |
| EBITDA | -$43.43M | -$16.91M |
| EPS (Diluted) | -$12.68 | -$0.83 |
Returns
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -172.3% | -53.2% |
| Return on Assets (ROA) | -127.6% | -40.9% |
| Return on Capital Employed (ROCE) | -87.8% | -38.1% |
Balance sheet
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $53.46M | $61.43M |
| Net Cash (Debt) | $53.46M | $15.35M |
| Net Cash Per Share | $5.96 | $0.66 |
| Equity (Book Value) | $49.40M | $49.09M |
| Book Value Per Share | $5.51 | $1.37 |
| Tangible Book Value | $49.40M | $23.52M |
| Working Capital | $49.48M | $76.81M |
Financial position
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Current Ratio | 7.85 | 3.34 |
| Quick Ratio | 7.41 | 2.44 |
Cash flow (trailing twelve months)
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$42.11M | -$12.35M |
Efficiency
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$1.41K | -$703.34K |
| Employee Count | 30,000 | 74 |
Dividends and yields
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Earnings Yield | -57.2% | -23.3% |
Shares
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Shares Outstanding | 8,967,690 | 58,127,000 |
| Shares Change (YoY) | 275.2% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Shares Held by Institutions | 71.4% | 59.4% |
Scores
| Measure | ProMIS Neurosciences | Industry median |
|---|---|---|
| Altman Z-Score | 0.88 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from ProMIS Neurosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.